Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

Dr David Stamler’s Biotech Showcase Presentation

January 7, 2019August 16, 2022 Alterity Therapeutics

Prana Biotechnology BSC Presntation 20180107 FINAL

2019

Post navigation

Prana Presents at Biotech Showcase

Prana receives Orphan Designation for PBT434 for treatment of MSA

Related Posts

Alterity Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

January 5, 2022August 16, 2022

Prana Completes Recruitment in Huntington Trial

July 17, 2013August 16, 2022

Quarterly Cash Flow Report

October 30, 2019August 16, 2022

Recent Posts

Chairman’s Address 2023 Annual General Meeting
AGM 2023 Presentation
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
Alterity Therapeutics Raises $4.8M AUD in Placement
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065